In addition, all nitrogen-containing bisphosphonates have been used as first-line drugs for the treatment of osteoporosis, due to their ability to inhibit farnesyl pyrophosphate synthase, an indispensable enzyme for cell function and survival of osteoclasts [87,88]. This evidence concerns the gene FDPS and osteoporosis.